Cargando…

Effect of splenectomy on the outcomes in patients with cirrhosis receiving transjugular intrahepatic portosystemic shunt

BACKGROUND AND AIM: Patients indicated to transjugular intrahepatic portosystemic shunt (TIPS) placement may have splenectomy history due to thrombocytopenia. This study aimed to evaluate the effect of prior splenectomy on TIPS procedure and post‐TIPS outcomes. METHODS: We conducted a longitudinal a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chongtu, Liu, Jiacheng, Shi, Qin, Huang, Songjiang, Zhou, Chen, Wang, Yingliang, Li, Tongqiang, Chen, Yang, Xiong, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518516/ https://www.ncbi.nlm.nih.gov/pubmed/33973270 http://dx.doi.org/10.1111/jgh.15543

Ejemplares similares

The combination of balloon-assisted antegrade transvenous obliteration and transjugular intrahepatic portosystemic shunt for the management of cardiofundal varices hemorrhage
por: Liu, Jiacheng, et al.
Publicado: (2020)

The impact of thrombocytopenia on variceal bleeding in cirrhotic patients with transjugular intrahepatic portosystemic shunt
por: Chen, Yang, et al.
Publicado: (2023)

Potential Benefits of Underdilation of 8-mm Covered Stent in Transjugular Intrahepatic Portosystemic Shunt Creation
por: Liu, Jiacheng, et al.
Publicado: (2021)

Changes and influencing factors of liver volume after transjugular intrahepatic portosystemic shunt: a retrospective cohort study
por: Bai, Yaowei, et al.
Publicado: (2023)

Racial disparities in transjugular intrahepatic portosystemic shunt procedure outcomes
por: Helzberg, James H, et al.
Publicado: (2022)

Using transjugular intrahepatic portosystemic shunt as the first‐line therapy in secondary prophylaxis of variceal hemorrhage
por: Liu, Jiacheng, et al.
Publicado: (2019)

Dynamic changes in liver function after transjugular intrahepatic portosystemic shunt in patients with cirrhosis
por: Wang, Chaoyang, et al.
Publicado: (2022)

First reports of clinical effects of transjugular intrahepatic portosystemic shunt in four patients with cirrhotic ascites refractory to tolvaptan
por: Tsuruya, Kota, et al.
Publicado: (2023)

Mild Prolongation of Prothrombin Time Does Not Affect the Safety and Prognosis of Transjugular Intrahepatic Portal Shunt: Based on Real-World Data
por: Bai, Yaowei, et al.
Publicado: (2023)

Inclusion of sarcopenia improves the prognostic value of MELD score in patients after transjugular intrahepatic portosystemic shunt
por: Bai, Yao-wei, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020
por: Horhat, Adelina, et al.
Publicado: (2021)

Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update
por: Rajesh, Sasidharan, et al.
Publicado: (2020)

A new choice of stent for transjugular intrahepatic portosystemic shunt creation: Viabahn ePTFE covered stent/bare metal stent combination
por: Liu, Jiacheng, et al.
Publicado: (2020)

Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Schistosomiasis-Induced Liver Fibrosis
por: Liu, Jiacheng, et al.
Publicado: (2019)

Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial)
por: de Wit, K, et al.
Publicado: (2020)

Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial
por: Qi, Xingshun, et al.
Publicado: (2013)

The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips
por: Fanelli, Fabrizio
Publicado: (2014)

Risk of hernia-related complications after transjugular intrahepatic portosystemic shunt creation in patients with pre-existing ventral abdominal hernias: 15-year experience at a quaternary medical center
por: McDaniel, Charles, et al.
Publicado: (2022)

Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis
por: Bucsics, Theresa, et al.
Publicado: (2022)

Parallel Shunt for the Treatment of Transjugular Intrahepatic Portosystemic Shunt Dysfunction
por: Luo, Xuefeng, et al.
Publicado: (2013)

Efficacy and safety of laparoscopic splenectomy for hypersplenism secondary to portal hypertension after transjugular intrahepatic portosystemic shunt
por: Li, Yingying, et al.
Publicado: (2021)

Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Refractory Transudative Chylothorax due to Liver Cirrhosis
por: Khaliq, Muhammad Farhan, et al.
Publicado: (2020)

Impact of transjugular intrahepatic portosystemic shunt creation on the central lymphatic system in liver cirrhosis
por: Pieper, Claus Christian, et al.
Publicado: (2021)

Pediatric liver cirrhosis interventional procedures: from biopsy to transjugular intrahepatic portosystemic shunt
por: Natali, Gian Luigi, et al.
Publicado: (2022)

Molecular targeted therapy causes hepatic encephalopathy in patients after Transjugular intrahepatic portosystemic shunt (TIPS): A case report and literature review
por: Zhou, Chen, et al.
Publicado: (2022)

Incidence of portal vein thrombosis after splenectomy and its influence on transjugular intrahepatic portosystemic shunt stent patency
por: Dong, Fang, et al.
Publicado: (2019)

Prognosis after splenectomy plus pericardial devascularization vs transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding
por: Qi, Wei-Li, et al.
Publicado: (2023)

Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt
por: Praktiknjo, Michael, et al.
Publicado: (2019)

Effects of transjugular intrahepatic portosystemic shunt using the Viatorr stent on hepatic reserve function in patients with cirrhosis
por: Yao, Xin, et al.
Publicado: (2021)

Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites
por: Stockhoff, Lena, et al.
Publicado: (2020)

The Impact of Transjugular Intrahepatic Portosystemic Shunt on Nutrition in Liver Cirrhosis Patients: A Systematic Review
por: Gazda, Jakub, et al.
Publicado: (2023)

Transcaval Transjugular Intrahepatic Portosystemic Shunt: Preliminary Clinical Results
por: Lee, Kwang-Hun, et al.
Publicado: (2003)

Quality Improvement Guidelines for Transjugular Intrahepatic Portosystemic Shunt (TIPS)
por: Krajina, Antonin, et al.
Publicado: (2012)

Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
por: Tripathi, Dhiraj, et al.
Publicado: (2020)

Transjugular intrahepatic portosystemic shunt assisted with trans-splenic access
por: Cheng, Zhang, et al.
Publicado: (2019)

Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites in Gaucher Disease
por: Adhyaru, Kunal, et al.
Publicado: (2022)

Biliary Obstruction After Transjugular Intrahepatic Portosystemic Shunt Placement
por: Patel, Feenalie, et al.
Publicado: (2021)

Modified gun-sight transjugular intrahepatic portosystemic shunt technique
por: Lukies, Matthew, et al.
Publicado: (2022)

Transjugular intrahepatic portosystemic shunt for repeated bleeding of hemorrhoids caused by severe portal hypertension with ectopic varices: A case report
por: Shi, Qin, et al.
Publicado: (2020)

Transjugular Intrahepatic Portosystemic Shunt Versus Surgical Shunting in the Management of Portal Hypertension
por: Huang, Long, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f2cuda8me5ercihbt5k92ejp8c